Effect of methylprednisolone on plasma lipid peroxidation induced by lipopolysaccharide

T. Kouno, T. Egashira, Fusako Takayama, Y. Kudo, Y. Yamanaka

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The effects of methylprednisolone succinate (MP) on plasma lipid peroxidation, plasma SOD activity and superoxide production in polymorphonuclear leukocytes (PMNs) induced by lipopolysaccharide (LPS) were examined in rats in vivo and in vitro. In rats subjected to LPS treatment, plasma phosphatidylcholine hydroperoxide (PCOOH) levels significantly increased, and the plasma Cu,Zn-SOD activity decreased by about 75%. When rats were given 30 mg/kg of MP intravenously, MP suppressed the elevation of plasma PCOOH levels and partially inhibited the decrease in plasma Cu,Zn-SOD activity. MP also suppressed PMA-induced superoxide production in PMNs primed by LPS. In in vitro experiments, low concentrations of MP had no effect on NADPH-dependent lipid peroxidation, but 4 mM MP produced 50% inhibition. MP had little effect on PMA-induced superoxide production in PMNs primed by LPS. Moreover, MP had no radical-trapping effect on superoxide, hydroxyl radical and stable DPPH radical. These results suggest that the suppressive effect of plasma lipid peroxidation by MP is not due to radical-trapping effects or preventive anti-oxidation, but may involve the suppression of the lipid chain reaction in liver membrane resulting from PMA-induced superoxide anions generated by PMNs.

Original languageEnglish
Pages (from-to)163-169
Number of pages7
JournalJapanese Journal of Pharmacology
Volume64
Issue number3
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Methylprednisolone Hemisuccinate
Methylprednisolone
Lipid Peroxidation
Lipopolysaccharides
Superoxides
NADP
Hydroxyl Radical
Neutrophils

Keywords

  • Lipid peroxidation
  • Lipopolysaccharide
  • Methylprednisolone
  • Plasma phosphatidylcholine hydroperoxide
  • Polymorphonuclear leukocyte

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effect of methylprednisolone on plasma lipid peroxidation induced by lipopolysaccharide. / Kouno, T.; Egashira, T.; Takayama, Fusako; Kudo, Y.; Yamanaka, Y.

In: Japanese Journal of Pharmacology, Vol. 64, No. 3, 1994, p. 163-169.

Research output: Contribution to journalArticle

Kouno, T. ; Egashira, T. ; Takayama, Fusako ; Kudo, Y. ; Yamanaka, Y. / Effect of methylprednisolone on plasma lipid peroxidation induced by lipopolysaccharide. In: Japanese Journal of Pharmacology. 1994 ; Vol. 64, No. 3. pp. 163-169.
@article{8f17045fa2644f42b0d6df2a9c1bbd30,
title = "Effect of methylprednisolone on plasma lipid peroxidation induced by lipopolysaccharide",
abstract = "The effects of methylprednisolone succinate (MP) on plasma lipid peroxidation, plasma SOD activity and superoxide production in polymorphonuclear leukocytes (PMNs) induced by lipopolysaccharide (LPS) were examined in rats in vivo and in vitro. In rats subjected to LPS treatment, plasma phosphatidylcholine hydroperoxide (PCOOH) levels significantly increased, and the plasma Cu,Zn-SOD activity decreased by about 75{\%}. When rats were given 30 mg/kg of MP intravenously, MP suppressed the elevation of plasma PCOOH levels and partially inhibited the decrease in plasma Cu,Zn-SOD activity. MP also suppressed PMA-induced superoxide production in PMNs primed by LPS. In in vitro experiments, low concentrations of MP had no effect on NADPH-dependent lipid peroxidation, but 4 mM MP produced 50{\%} inhibition. MP had little effect on PMA-induced superoxide production in PMNs primed by LPS. Moreover, MP had no radical-trapping effect on superoxide, hydroxyl radical and stable DPPH radical. These results suggest that the suppressive effect of plasma lipid peroxidation by MP is not due to radical-trapping effects or preventive anti-oxidation, but may involve the suppression of the lipid chain reaction in liver membrane resulting from PMA-induced superoxide anions generated by PMNs.",
keywords = "Lipid peroxidation, Lipopolysaccharide, Methylprednisolone, Plasma phosphatidylcholine hydroperoxide, Polymorphonuclear leukocyte",
author = "T. Kouno and T. Egashira and Fusako Takayama and Y. Kudo and Y. Yamanaka",
year = "1994",
language = "English",
volume = "64",
pages = "163--169",
journal = "Japanese Journal of Pharmacology",
issn = "0021-5198",
publisher = "Japanese Pharmacological Society",
number = "3",

}

TY - JOUR

T1 - Effect of methylprednisolone on plasma lipid peroxidation induced by lipopolysaccharide

AU - Kouno, T.

AU - Egashira, T.

AU - Takayama, Fusako

AU - Kudo, Y.

AU - Yamanaka, Y.

PY - 1994

Y1 - 1994

N2 - The effects of methylprednisolone succinate (MP) on plasma lipid peroxidation, plasma SOD activity and superoxide production in polymorphonuclear leukocytes (PMNs) induced by lipopolysaccharide (LPS) were examined in rats in vivo and in vitro. In rats subjected to LPS treatment, plasma phosphatidylcholine hydroperoxide (PCOOH) levels significantly increased, and the plasma Cu,Zn-SOD activity decreased by about 75%. When rats were given 30 mg/kg of MP intravenously, MP suppressed the elevation of plasma PCOOH levels and partially inhibited the decrease in plasma Cu,Zn-SOD activity. MP also suppressed PMA-induced superoxide production in PMNs primed by LPS. In in vitro experiments, low concentrations of MP had no effect on NADPH-dependent lipid peroxidation, but 4 mM MP produced 50% inhibition. MP had little effect on PMA-induced superoxide production in PMNs primed by LPS. Moreover, MP had no radical-trapping effect on superoxide, hydroxyl radical and stable DPPH radical. These results suggest that the suppressive effect of plasma lipid peroxidation by MP is not due to radical-trapping effects or preventive anti-oxidation, but may involve the suppression of the lipid chain reaction in liver membrane resulting from PMA-induced superoxide anions generated by PMNs.

AB - The effects of methylprednisolone succinate (MP) on plasma lipid peroxidation, plasma SOD activity and superoxide production in polymorphonuclear leukocytes (PMNs) induced by lipopolysaccharide (LPS) were examined in rats in vivo and in vitro. In rats subjected to LPS treatment, plasma phosphatidylcholine hydroperoxide (PCOOH) levels significantly increased, and the plasma Cu,Zn-SOD activity decreased by about 75%. When rats were given 30 mg/kg of MP intravenously, MP suppressed the elevation of plasma PCOOH levels and partially inhibited the decrease in plasma Cu,Zn-SOD activity. MP also suppressed PMA-induced superoxide production in PMNs primed by LPS. In in vitro experiments, low concentrations of MP had no effect on NADPH-dependent lipid peroxidation, but 4 mM MP produced 50% inhibition. MP had little effect on PMA-induced superoxide production in PMNs primed by LPS. Moreover, MP had no radical-trapping effect on superoxide, hydroxyl radical and stable DPPH radical. These results suggest that the suppressive effect of plasma lipid peroxidation by MP is not due to radical-trapping effects or preventive anti-oxidation, but may involve the suppression of the lipid chain reaction in liver membrane resulting from PMA-induced superoxide anions generated by PMNs.

KW - Lipid peroxidation

KW - Lipopolysaccharide

KW - Methylprednisolone

KW - Plasma phosphatidylcholine hydroperoxide

KW - Polymorphonuclear leukocyte

UR - http://www.scopus.com/inward/record.url?scp=0028210496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028210496&partnerID=8YFLogxK

M3 - Article

C2 - 8022118

AN - SCOPUS:0028210496

VL - 64

SP - 163

EP - 169

JO - Japanese Journal of Pharmacology

JF - Japanese Journal of Pharmacology

SN - 0021-5198

IS - 3

ER -